Do you want to read an article? Please log in or register.
Baseline OCT Biomarkers Predicting Visual Outcomes in Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Macular Diseases
Related content
Macular Diseases
Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Clin Exp Ophthalmol
Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA
doi: 10.1111/ceo.14559
RECOMMENDED
Macular Diseases
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Berni A, Coletto A, Li J, Shen M, Bandello F, Reibaldi M, Borrelli E
doi: 10.1016/j.oret.2025.01.011
Macular Diseases
Impact of Duration of Exposure to Intraretinal Fluid on Visual Outcomes in Neovascular Age-Related Macular Degeneration
Ophthalmol Retina
Steinle NC, McCullough AJ, Silva FQ, Du W, Moini H, Singh RP
doi: 10.1016/j.oret.2024.12.018
Macular Diseases
Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis
Surv Ophthalmol
Hoven E, Michelet JT, Vettore MV, Lagali N
doi: 10.1016/j.survophthal.2024.09.011
Macular DiseasesRetinal Diseases
Persistence of Retinal Fluid after Anti-VEGF treatment for neovascular age-related macular degeneration: A Systematic Review and Meta-Analysis
Ophthalmol Retina
Ting Yap DW, Jyn Tan BK, Yi Chong KT, Wong TY, Gemmy Cheung CM
doi: 10.1016/j.oret.2025.01.010
Macular Diseases
Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis
Acta Ophthalmol
Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E, Cehofski LJ, Ferro Desideri L, van Dijk EHC, Faber C, Grauslund J, Hajari JN, Huemer J, Klefter ON, Krogh Nielsen M, Sabaner MC, Schneider M, Subhi Y
doi: 10.1111/aos.17506
Macular Diseases
Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland
J Med Econ
Ambresin A, Quist SW, Boer M, Maamari S, Barthelmes D
doi: 10.1080/13696998.2025.2536420
Macular Diseases
Real-world outcomes of aflibercept 8 mg in patients previously treated for neovascular age-related macular degeneration
Acta Ophthalmol
Abu Ishkheidem I, Inci E, Breimer M, Silfverswärd ST, Zetterberg M, Grönlund MA
doi: 10.1111/aos.17590
Macular Diseases
Acceptance of the Disease in Patients Diagnosed with Neovascular Age-Related Macular Degeneration Depending on Visual Parameters-Before and After a Series of Seven Intravitreal Injections
J Clin Med
Nowak M, Cybulska AM, Schneider-Matyka D, Grochans E, Walaszek I, Panczyk M, Nowicki GJ, Rachubińska K
doi: 10.3390/jcm14020447